Citigroup’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-35
| Closed | – | – | 5676 |
|
|
2022
Q2 | $0 | Sell |
35
-59
| -63% | – | ﹤0.01% | 5939 |
|
|
2022
Q1 | $2K | Sell |
94
-205
| -69% | -$4.36K | ﹤0.01% | 5288 |
|
|
2021
Q4 | $11K | Buy |
299
+166
| +125% | +$6.11K | ﹤0.01% | 4773 |
|
|
2021
Q3 | $10K | Buy |
133
+106
| +393% | +$7.97K | ﹤0.01% | 4719 |
|
|
2021
Q2 | $4K | Sell |
27
-12
| -31% | -$1.78K | ﹤0.01% | 5210 |
|
|
2021
Q1 | $11K | Sell |
39
-694
| -95% | -$196K | ﹤0.01% | 4944 |
|
|
2020
Q4 | $457K | Buy |
+733
| New | +$457K | ﹤0.01% | 2694 |
|